The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.

View Drug Discovery Today now »»

Our September issue review highlights includes:

• Future directions for peptide therapeutics development

• Therapeutic potential of neuregulin-1 in cardiovascular diseases

• The virtue of translational PKPD modeling in drug discovery

• Parthenolide: from plant shoots to cancer roots

Cover Story
The leading story of this issue of Drug Discovery Today provides an overview of the pipeline, including therapeutic area and molecular targets, with a focus on glucagon-like peptide 1 receptor agonists. In addition, areas for potential expansion, for example, constrained peptides and peptide–drug conjugates, are profiled.

Remember - reading and downloading Drug Discovery Today is easy and free - you can access the issue at:

http://e-ditionsbyfry.com/olive/ODE/DDT/Default.aspx?href=DDT/2013/09/01

Enjoy your digital edition!

Best Regards,

Steve Carney
Editor
Drug Discovery Today
www.drugdiscoverytoday.com